These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 30625351)

  • 1. Hyaluronic acid and hyaluronic acid: Sucrose nanogels for hydrophobic cancer drug delivery.
    Sagbas Suner S; Ari B; Onder FC; Ozpolat B; Ay M; Sahiner N
    Int J Biol Macromol; 2019 Apr; 126():1150-1157. PubMed ID: 30625351
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thermoresponsive hyaluronic acid nanogels as hydrophobic drug carrier to macrophages.
    Fernandes Stefanello T; Szarpak-Jankowska A; Appaix F; Louage B; Hamard L; De Geest BG; van der Sanden B; Nakamura CV; Auzély-Velty R
    Acta Biomater; 2014 Nov; 10(11):4750-4758. PubMed ID: 25110287
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeted intracellular protein delivery based on hyaluronic acid-green tea catechin nanogels.
    Liang K; Ng S; Lee F; Lim J; Chung JE; Lee SS; Kurisawa M
    Acta Biomater; 2016 Mar; 33():142-52. PubMed ID: 26785145
    [TBL] [Abstract][Full Text] [Related]  

  • 4. pH responsive biodegradable nanogels for sustained release of bleomycin.
    Sahu P; Kashaw SK; Kushwah V; Sau S; Jain S; Iyer AK
    Bioorg Med Chem; 2017 Sep; 25(17):4595-4613. PubMed ID: 28734664
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hyaluronic acid-based nanogel-drug conjugates with enhanced anticancer activity designed for the targeting of CD44-positive and drug-resistant tumors.
    Wei X; Senanayake TH; Warren G; Vinogradov SV
    Bioconjug Chem; 2013 Apr; 24(4):658-68. PubMed ID: 23547842
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fabrication of dihydroxyflavone-conjugated hyaluronic acid nanogels for targeted antitumoral effect.
    Choi YR; Kim HJ; Ahn GY; Lee MJ; Park JR; Jun DR; Ryu TK; Park JW; Shin E; Choi SW
    Colloids Surf B Biointerfaces; 2018 Nov; 171():690-697. PubMed ID: 30114654
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis by AGET ATRP of degradable nanogel precursors for in situ formation of nanostructured hyaluronic acid hydrogel.
    Bencherif SA; Washburn NR; Matyjaszewski K
    Biomacromolecules; 2009 Sep; 10(9):2499-507. PubMed ID: 19711888
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mucoadhesive Thiolated Hyaluronic Acid/Pluronic F127 Nanogel Formation
    Li F; Chen X; He Y; Peng Z
    ACS Appl Bio Mater; 2024 Mar; 7(3):1976-1989. PubMed ID: 38447202
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acetylated hyaluronic acid/photosensitizer conjugate for the preparation of nanogels with controllable phototoxicity: synthesis, characterization, autophotoquenching properties, and in vitro phototoxicity against HeLa cells.
    Li F; Bae BC; Na K
    Bioconjug Chem; 2010 Jul; 21(7):1312-20. PubMed ID: 20586473
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Delivery of Small Molecule EF2 Kinase Inhibitor for Breast and Pancreatic Cancer Cells Using Hyaluronic Acid Based Nanogels.
    Comert Onder F; Sagbas Suner S; Sahiner N; Ay M; Ozpolat B
    Pharm Res; 2020 Mar; 37(3):63. PubMed ID: 32133571
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mesoporous, degradable hyaluronic acid microparticles for sustainable drug delivery application.
    Sahiner N; Suner SS; Ayyala RS
    Colloids Surf B Biointerfaces; 2019 May; 177():284-293. PubMed ID: 30769230
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Target-specific intracellular delivery of siRNA using degradable hyaluronic acid nanogels.
    Lee H; Mok H; Lee S; Oh YK; Park TG
    J Control Release; 2007 Jun; 119(2):245-52. PubMed ID: 17408798
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Redox Responsive Hyaluronic Acid Nanogels for Treating RHAMM (CD168) Over-expressive Cancer, both Primary and Metastatic Tumors.
    Yang C; Li C; Zhang P; Wu W; Jiang X
    Theranostics; 2017; 7(6):1719-1734. PubMed ID: 28529647
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nanogel delivery systems for cationic peptides: More than a 'One Size Fits All' solution.
    Kłodzińska SN; Wang Q; Molchanova N; Mahmoudi N; Vallooran JJ; Hansen PR; Jenssen H; Mørck Nielsen H
    J Colloid Interface Sci; 2024 Jun; 663():449-457. PubMed ID: 38417296
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hyaluronic acid nanogels with enzyme-sensitive cross-linking group for drug delivery.
    Yang C; Wang X; Yao X; Zhang Y; Wu W; Jiang X
    J Control Release; 2015 May; 205():206-17. PubMed ID: 25665867
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel propyl karaya gum nanogels for bosentan: In vitro and in vivo drug delivery performance.
    Laha B; Das S; Maiti S; Sen KK
    Colloids Surf B Biointerfaces; 2019 Aug; 180():263-272. PubMed ID: 31059984
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Redox-Responsive Nanogel with Intracellular Reconstruction and Programmable Drug Release for Targeted Tumor Therapy.
    Tian Y; Tian R; Chen L; Jin R; Feng Y; Bai Y; Chen X
    Macromol Rapid Commun; 2019 Apr; 40(8):e1800824. PubMed ID: 30779386
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A new multiresponsive drug delivery system using smart nanogels.
    Demirel GB; von Klitzing R
    Chemphyschem; 2013 Aug; 14(12):2833-40. PubMed ID: 23794381
    [TBL] [Abstract][Full Text] [Related]  

  • 19. pH-Responsive Fluorescence Enhanced Nanogel for Targeted Delivery of AUR and CDDP Against Breast Cancer.
    Cao Z; Li W; Liu R; Li C; Song Y; Liu G; Chen Y; Lu C; Lu A; Liu Y
    Int J Nanomedicine; 2020; 15():8369-8382. PubMed ID: 33149581
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel crosslinked hyaluronic acid nanogel for drug delivery.
    Pedrosa SS; Gonçalves C; David L; Gama M
    Macromol Biosci; 2014 Nov; 14(11):1556-68. PubMed ID: 25088667
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.